scispace - formally typeset
K

Klaus I. Matthaei

Researcher at Australian National University

Publications -  136
Citations -  10763

Klaus I. Matthaei is an academic researcher from Australian National University. The author has contributed to research in topics: Interleukin 5 & Eosinophil. The author has an hindex of 53, co-authored 136 publications receiving 10283 citations. Previous affiliations of Klaus I. Matthaei include King Saud University & King Khalid University.

Papers
More filters
Journal ArticleDOI

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.

TL;DR: Results indicate that IL-5 and eosinophils are central mediators in the pathogenesis of allergic lung disease.
Journal ArticleDOI

IL-5-Deficient Mice Have a Developmental Defect in CD5+ B-1 Cells and Lack Eosinophilia but Have Normal Antibody and Cytotoxic T Cell Responses

TL;DR: Mice deficient in interleukin-5 (IL-5-/- mice) were generated by gene targeting in embryonal stem cells, indicating that increased eosinophils do not play a significant role in the host defence in this parasite model.
Journal ArticleDOI

The role of interleukin-6 in mucosal IgA antibody responses in vivo

TL;DR: A critical role for IL-6 in vivo in the development of local IgA antibody responses is demonstrated and the effectiveness of vector-directed cytokine gene therapy is illustrated.
Journal ArticleDOI

Histone variant H2A.Z is required for early mammalian development.

TL;DR: It is shown for the first time that a mammalian histone variant, H2A.Z, plays a critical role in early development, and it is concluded that this hist one variant plays a pivotal role in establishing the chromatin structures required for the complex patterns of gene expression essential for normal mammalian development.
Journal ArticleDOI

Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice.

TL;DR: It is proposed that eotaxin secreted from inflamed tissue may play an important role in initiating both blood and tissue eosinophilia in the early phases of allergic inflammation.